Diabetic Dyslipidemia and Cardiovascular Risk

被引：6
作者：
Eckel, Robert H. [1 ]
机构：
[1] Univ Colorado Denver, Div Endocrinol Diabet & Metab, Aurora, CO 80045 USA
来源：
CURRENT DIABETES REPORTS | 2008年 / 8卷 / 06期
关键词：
D O I：
10.1007/s11892-008-0072-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：421 / 423
页数：3
相关论文
共 21 条
[11]   Simvastatin with or without ezetimibe in familial hypercholesterolemia [J].
Kastelein, John J. P. ;
Akdim, Fatima ;
Stroes, Erik S. G. ;
Zwinderman, Aeilko H. ;
Bots, Michiel L. ;
Stalenhoef, Anton F. H. ;
Visseren, Frank L. J. ;
Sijbrands, Eric J. G. ;
Trip, Mieke D. ;
Stein, Evan A. ;
Gaudet, Daniel ;
Duivenvoorden, Raphael ;
Veltri, Enrico P. ;
Marais, A. David ;
de Groot, Eric .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14) :1431-1443
[12]   Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients [J].
Koppes, LLJ ;
Dekker, JM ;
Hendriks, HFJ ;
Bouter, LM ;
Heine, RJ .
DIABETOLOGIA, 2006, 49 (04) :648-652
[13]   LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients [J].
Lee, SJ ;
Campos, H ;
Moye, LA ;
Sacks, FM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) :853-858
[14]   Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes [J].
Liu, J ;
Sempos, C ;
Donahue, RP ;
Dorn, J ;
Trevisan, M ;
Grundy, SM .
DIABETES CARE, 2005, 28 (08) :1916-1921
[15]   Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes - The Strong Heart Study [J].
Lu, WQ ;
Resnick, HE ;
Jablonski, KA ;
Jones, KL ;
Jain, AK ;
Howard, WJ ;
Robbins, DC ;
Howard, BV .
DIABETES CARE, 2003, 26 (01) :16-23
[16]   Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies [J].
Mazzone, Theodore ;
Chait, Alan ;
Plutzky, Jorge .
LANCET, 2008, 371 (9626) :1800-1809
[17]   Low synthesis and high absorption of cholesterol characterize type 1 diabetes [J].
Miettinen, TA ;
Gylling, H ;
Ruominen, J ;
Simonen, P ;
Koivisto, V .
DIABETES CARE, 2004, 27 (01) :53-58
[18]   What is the most effective strategy for managing diabetic dyslipidaemia? [J].
Reasner, CA .
ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (03) :21-27
[19]   Bile acid sequestrants and the treatment of type 2 diabetes mellitus [J].
Staels, Bart ;
Kuipers, Folkert .
DRUGS, 2007, 67 (10) :1383-1392
[20]   Treatment of diabetic dyslipoproteinemia [J].
Steinmetz, A .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2003, 111 (05) :239-245
123